» Articles » PMID: 33274014

Current Understanding of Glucose Transporter 4 Expression and Functional Mechanisms

Overview
Specialty Biochemistry
Date 2020 Dec 4
PMID 33274014
Citations 29
Authors
Affiliations
Soon will be listed here.
Abstract

Glucose is used aerobically and anaerobically to generate energy for cells. Glucose transporters (GLUTs) are transmembrane proteins that transport glucose across the cell membrane. Insulin promotes glucose utilization in part through promoting glucose entry into the skeletal and adipose tissues. This has been thought to be achieved through insulin-induced GLUT4 translocation from intracellular compartments to the cell membrane, which increases the overall rate of glucose flux into a cell. The insulin-induced GLUT4 translocation has been investigated extensively. Recently, significant progress has been made in our understanding of GLUT4 expression and translocation. Here, we summarized the methods and reagents used to determine the expression levels of mRNA and GLUT4 protein, and GLUT4 translocation in the skeletal muscle, adipose tissues, heart and brain. Overall, a variety of methods such real-time polymerase chain reaction, immunohistochemistry, fluorescence microscopy, fusion proteins, stable cell line and transgenic animals have been used to answer particular questions related to GLUT4 system and insulin action. It seems that insulin-induced GLUT4 translocation can be observed in the heart and brain in addition to the skeletal muscle and adipocytes. Hormones other than insulin can induce GLUT4 translocation. Clearly, more studies of GLUT4 are warranted in the future to advance of our understanding of glucose homeostasis.

Citing Articles

The interplay of factors in metabolic syndrome: understanding its roots and complexity.

Islam M, Wei P, Suzauddula M, Nime I, Feroz F, Acharjee M Mol Med. 2024; 30(1):279.

PMID: 39731011 PMC: 11673706. DOI: 10.1186/s10020-024-01019-y.


Investigating the crosstalk between and in 3T3-L1 adipocyte differentiation.

Laddha A, Wahane A, Bahal R, Manautou J Front Mol Biosci. 2024; 11:1498946.

PMID: 39717760 PMC: 11663720. DOI: 10.3389/fmolb.2024.1498946.


Statin Use and Hyperglycemia: Do Statins Cause Diabetes?.

Bredefeld C, Choi P, Cullen T, Nicolich-Henkin S, Waters L Curr Atheroscler Rep. 2024; 27(1):18.

PMID: 39699704 DOI: 10.1007/s11883-024-01266-8.


Photobiomodulation for diabetes and its complications: a review of general presentation, mechanisms and efficacy.

Wang K, Zhao H, Zhao X, Zhang X, Zhang W, Cheng Y Ann Med. 2024; 56(1):2433684.

PMID: 39607829 PMC: 11610354. DOI: 10.1080/07853890.2024.2433684.


Molecular, cellular, and metabolic insights of cinnamon (Cinnamomum zeylanicum) advantages in diabetes and related complications: condiment or medication?.

Beheshti A, Qazvini M, Abeq M, Abedi E, Fadaei M, Fadaei M Naunyn Schmiedebergs Arch Pharmacol. 2024; .

PMID: 39589531 DOI: 10.1007/s00210-024-03644-0.


References
1.
Chen L, Tuo B, Dong H . Regulation of Intestinal Glucose Absorption by Ion Channels and Transporters. Nutrients. 2016; 8(1). PMC: 4728656. DOI: 10.3390/nu8010043. View

2.
Sasaki T, Minoshima S, Shiohama A, Shintani A, Shimizu A, Asakawa S . Molecular cloning of a member of the facilitative glucose transporter gene family GLUT11 (SLC2A11) and identification of transcription variants. Biochem Biophys Res Commun. 2001; 289(5):1218-24. DOI: 10.1006/bbrc.2001.6101. View

3.
Webster I, Friedrich S, Lochner A, Huisamen B . AMP kinase activation and glut4 translocation in isolated cardiomyocytes. Cardiovasc J Afr. 2010; 21(2):72-8. PMC: 3734761. View

4.
Shoop S, Maria Z, Campolo A, Rashdan N, Martin D, Lovern P . Glial Growth Factor 2 Regulates Glucose Transport in Healthy Cardiac Myocytes and During Myocardial Infarction via an Akt-Dependent Pathway. Front Physiol. 2019; 10:189. PMC: 6445869. DOI: 10.3389/fphys.2019.00189. View

5.
Carlson C, Rondinone C . Pharmacological inhibition of p38 MAP kinase results in improved glucose uptake in insulin-resistant 3T3-L1 adipocytes. Metabolism. 2005; 54(7):895-901. DOI: 10.1016/j.metabol.2005.02.003. View